Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVA: Evista vs Alendronate in Osteoporosis
NCT00035971Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of raloxifene in osteoporosis, sponsored by Eli Lilly and Company. Status: completed.
02
Drugs
raloxifene
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00035971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00035971.